Table 5.
Scoring System to Predict DFS or Recurrence After Hepatectomy in the Published Literature
| Author | Country | Year | AUC | Liver Function Reserve Indicators | Liver Cirrhosis | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Object | Study Endpoint | PVTT | BDTT | CTP | MELD | ALBI | Classification | RF | MVI | RF | ||||
| Hung et al38 | Hong Kong China | 2016 | 1-,3yr recurrence | No | NA | 0.675;0.746 | Yes | Yes | No | Y/N | No | NA | NA | |
| Zou et al39 | China | 2017 | BCLC-A HCC | 1-,2-,5yr DFS | No | NA | 0.645 | Yes | No | No | Y/N | Yes | NA | NA |
| Tokumitsu et al40 | Japan | 2018 | 1-,2yr recurrence | NA | NA | 0.78;0.74 | Yes | No | No | NA | NA | NA | NA | |
Abbreviations: DFS, disease-free survival; PVTT, portal vein tumor thrombosis; BDTT, bile duct tumor thrombosis; AUC, area under curve; CTP, child-turcotte-pugh; MELD, model for end-stage liver disease; ALBI, albumin-bilirubin; RF, risk factor; MVI, microvascular invasion; DFS, disease-free survival; Y/N, Yes/No, NA, not available.